Healthcare Press Releases
'Press Releases' Section describes most distant clients with latest product-specific, company-related updates is a key value addition to our members because they can use this platform as the easiest, earlier and the most effective means to get noticed quickly. Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Healthcare industry.
— To learn more on how to reach a suitable target audience by distributing / publicizing your content(the latest happenings about your company) as in 'Press Releases' through 'Global Healthcare Technology',This email address is being protected from spambots. You need JavaScript enabled to view it.
— To learn more on how to reach a suitable target audience by distributing / publicizing your content(the latest happenings about your company) as in 'Press Releases' through 'Global Healthcare Technology',
- Details
- Written by: BD (Becton, Dickinson and Company)
- Category: Press Releases
BD, a leading medical tech company, announces a new high-throughput single-cell multiomics instrument that could speed up discovery across various fields, without sacrificing sample quality.
- Company Name: BD
- Company/Org Logo:
- About Company: BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers,
- Person of Contact: Francesca DeMartino
- Designation: Head of Marketing
- Details
- Written by: Aspivix SA
- Category: Press Releases
Aspivix announces Carevix™ cervical stabilizer gets FDA 510(k) clearance, offering millions of women in the US less painful gynecological procedures.
- Company Name: Aspivix SA
- Company/Org Logo:
- About Company: ASPIVIX SA is a privately held medical device company based in Switzerland, dedicated to developing modern and gentle gynecological solutions that advance women's healthcare. The Company's innovative technology development and clinical program are supported by 4FOx Ventures, Zürcher Kantonalbank, HEMEX, Launchpad, Innosuisse, SPEI, EU research and innovation program Horizon 2020, and visionary angel investors.
- Person of Contact: Mathieu Horras
- Phone: +41 79 103 22 06
- Details
- Written by: Olympus
- Category: Press Releases
Olympus announced that it has been awarded a nationwide contract by Vizient Inc. for its smoke evacuation portfolio, including the OR-VAC™ Surgical Smoke Evacuator, Accessories and Tubing, Telescopic Smoke Pencil, Ultravision™ Generator and Accessories, and UHI-4 Insufflator. Effective February 1, 2023, the agreement offers Vizient members preferred pricing for these products.
- Company Name: Olympus
- Company/Org Logo:
- About Company: Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Olympus' portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of EndoTherapy instruments.
- Details
- Written by: Mikart, LLC
- Category: Press Releases
Mikart, LLC –a comprehensive contract development and manufacturing organization the completion of a new liquids and suspensions suite in Atlanta, Georgia.
- Company Name: Mikart, LLC
- Company/Org Logo:
- About Company: Mikart, LLC is a privately held contract development and manufacturing organization (CDMO) founded in 1975. Mikart focuses on small molecules, potent compounds, solid oral, combination products, suspensions, liquids, and serialized packaging services. The company has a full range of formulation, analytical, packaging and manufacturing services with a seamless development solution that minimizes the time-to-market from clinical work through commercial supply.
- Details
- Written by: Medline
- Category: Press Releases
Medline a new partnership with Connecticut-based Integrated UVC Solutions to help healthcare providers enhance UV disinfection practices.
- Company Name: Medline
- Company/Org Logo:
- About Company: Medline is a healthcare company; a manufacturer, distributor, and solutions provider focused on improving the overall operating performance of healthcare. Partnering with healthcare systems and facilities across the continuum of care, Medline provides the clinical and supply chain resources required for long-term financial viability in delivering high-quality care. With the scale of one of the country's largest companies and the agility of a family-led business, Medline is able to invest in its customers for the future and rapidly respond to a dynamically changing market with customized solutions. Headquartered in Northfield, Ill., Medline has 34,000+ employees worldwide and does business in more than 125 countries and territories.
- Details
- Written by: Datar Cancer Genetics
- Category: Press Releases
Datar Cancer Genetics Inc that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its 'TriNetra™-Glio'.
- Company Name: Datar Cancer Genetics
- Company/Org Logo:
- About Company: Datar Cancer Genetics is a global oncology research and applications company that is spearheading the development of non-invasive technologies for improved detection, treatment and management of cancer. The Company's state-of-the-art cancer research centre is NABL, ISO, CAP and CLIA accredited. The Company serves cancer patients and suspected cases in the UK, European Union, United States, GCC, and India. The Company has modern cancer research facilities in the US, UK, and India.